Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

[1]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[2]  John J. Rossi,et al.  The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.

[3]  A. Judge,et al.  Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. , 2008, Human gene therapy.

[4]  Dale L. Greiner,et al.  T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2008, Cell.

[5]  Christopher J. Miller,et al.  Whither or Wither Microbicides? , 2008, Science.

[6]  David P Wilson,et al.  The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics , 2008, Proceedings of the National Academy of Sciences.

[7]  Junji Kato,et al.  Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone , 2008, Nature Biotechnology.

[8]  Naoyuki Murata,et al.  Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[9]  D. Peer,et al.  Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target , 2008, Science.

[10]  F. Liu,et al.  Several serum proteins significantly decrease inflammatory response to lipid-based non-viral vectors. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  Shubiao Zhang,et al.  Cationic lipids and polymers mediated vectors for delivery of siRNA. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[12]  M. Breunig,et al.  Breaking up the correlation between efficacy and toxicity for nonviral gene delivery , 2007, Proceedings of the National Academy of Sciences.

[13]  J. Vishwanatha,et al.  Polymeric nanoparticles for sustained down-regulation of annexin A2 lead to reduction in proliferation and migration of prostate cancer cells , 2007 .

[14]  Justin Hanes,et al.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.

[15]  W. Gu,et al.  Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes , 2006, Cancer Gene Therapy.

[16]  Xudong Yuan,et al.  SiRNA drug delivery by biodegradable polymeric nanoparticles. , 2006, Journal of nanoscience and nanotechnology.

[17]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Y. Barenholz,et al.  Lipoplexes prepared from cationic liposomes and mammalian DNA induce CpG‐independent, direct cytotoxic effects in cell cultures and in mice , 2006, The journal of gene medicine.

[19]  Amy C Richards Grayson,et al.  Biophysical and Structural Characterization of Polyethylenimine-Mediated siRNA Delivery in Vitro , 2006, Pharmaceutical Research.

[20]  Sung Wan Kim,et al.  Current status of polymeric gene delivery systems. , 2006, Advanced drug delivery reviews.

[21]  Matthias John,et al.  RNAi-mediated gene silencing in non-human primates , 2006, Nature.

[22]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Lieberman,et al.  An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection , 2006, Nature.

[24]  U. Bachrach.  Naturally occurring polyamines: interaction with macromolecules. , 2005, Current protein & peptide science.

[25]  John P. Moore,et al.  Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion , 2005, Nature.

[26]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[27]  Judy Lieberman,et al.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.

[28]  Feng Liu,et al.  Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. , 2005, Advanced drug delivery reviews.

[29]  Wenlei Jiang,et al.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. , 2005, Advanced drug delivery reviews.

[30]  I. Adcock,et al.  The Journal of Inflammation , 2004, Journal of Inflammation.

[31]  G. Hannon,et al.  Unlocking the potential of the human genome with RNA interference , 2004, Nature.

[32]  X. Zhu,et al.  Polymer microspheres for controlled drug release. , 2004, International journal of pharmaceutics.

[33]  Stephen P. Fox,et al.  Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes: In Vitro and In Vivo Studies , 2004, Journal of drug targeting.

[34]  E. Gerner,et al.  Polyamine-dependent gene expression , 2003, Cellular and Molecular Life Sciences CMLS.

[35]  M. Manns,et al.  Caspase 8 small interfering RNA prevents acute liver failure in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[37]  John P. Moore,et al.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120 , 2003, Nature Medicine.

[38]  Jayanth Panyam,et al.  Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells , 2003, Pharmaceutical Research.

[39]  W. Saltzman,et al.  Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[40]  A. Stone.  Microbicides: a new approach to preventing HIV and other sexually transmitted infections , 2002, Nature Reviews Drug Discovery.

[41]  Jayanth Panyam,et al.  Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  J. Lieberman,et al.  siRNA-directed inhibition of HIV-1 infection , 2002, Nature Medicine.

[43]  A. I. Yudin,et al.  Diffusion of macromolecules and virus-like particles in human cervical mucus. , 2001, Biophysical journal.

[44]  T. Thomas,et al.  Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications , 2001, Cellular and Molecular Life Sciences CMLS.

[45]  Sanchita Bhattacharya,et al.  Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery , 1998, Gene Therapy.

[46]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[47]  K. Whaley,et al.  Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes , 1996, Nature Biotechnology.

[48]  J. Patton,et al.  (D) Routes of delivery: Case studies , 1992 .

[49]  L. Illum,et al.  (D) Routes of delivery: Case studies , 1992 .